Practical management of opioid rotation and equianalgesia
- PMID: 30464578
- PMCID: PMC6211309
- DOI: 10.2147/JPR.S170269
Practical management of opioid rotation and equianalgesia
Abstract
Purpose: To review the recent literature on opioid rotation (ie, switching from one opioid drug to another or changing an opioid's administration route) in cancer patients experiencing severe pain and to develop a novel equianalgesia table for use in routine clinical practice.
Methods: The MEDLINE database was searched with terms "cancer pain," "opioid rotation," "opioid switching," "opioid ratio," "opioid conversion ratio," and "opioid equianalgesia" for the major opioids (morphine, oxycodone, fentanyl, and hydromorphone) and the intravenous, subcutaneous, oral, and transdermal administration routes. Selected articles were assessed for the calculated or cited opioid dose ratio, bidirectionality, and use of the oral morphine equivalent daily dose or a direct drug-to-drug ratio.
Results: Twenty publications met our selection criteria and were analyzed in detail. We did not find any large-scale, prospective, double-blind randomized controlled trial with robust design, and most of the studies assessed relatively small numbers of patients. Bidirectionality was investigated in seven studies only.
Conclusion: The updated equianalgesic table presented here incorporates the latest data and provides information on bidirectionality. Despite the daily use of equianalgesic tables, they are not based on high-level scientific evidence. More clinical research is needed on this topic.
Keywords: equianalgesic dose; fentanyl; hydromorphone; morphine; opioid rotation; opioid switching; oxycodone.
Conflict of interest statement
Disclosure Yacine Hadjiat is an employee of Mundipharma and reports no other conflicts of interest in this work. Erwan Treillet and Sophie Laurent report no conflicts of interest in this work.
Figures





References
-
- Mercadante S, Bruera E. Opioid switching in cancer pain: From the beginning to nowadays. Crit Rev Oncol Hematol. 2016;99:241–248. - PubMed
-
- Lawlor PG, Bruera E. Side-effects of opioids in chronic pain treatment. Curr Opin Anaesthesiol. 1998;11(5):539–545. - PubMed
-
- Walters JB, Montagnini M. Current concepts in the management of opioid-induced constipation. J Opioid Manag. 2010;6(6):435–444. - PubMed
-
- Reimer K, Hopp M, Zenz M, et al. Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approach. Pharmacology. 2009;83(1):10–17. - PubMed
-
- Mccann S, Yaksh TL, von Gunten CF. Correlation between myoclonus and the 3-glucuronide metabolites in patients treated with morphine or hydromorphone: A pilot study. J Opioid Manag. 2010;6(2):87–94. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous